Results 231 to 240 of about 3,266,701 (358)
Pediatric heart transplantation: Current status and perspectives. [PDF]
Azeka E, Hase F, Tomimoto Y.
europepmc +1 more source
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang +7 more
wiley +1 more source
Genetic Spectrum, Clinical Characteristics, and Molecular Pathogenesis of Hypertrophic Cardiomyopathy Requiring Heart Transplantation. [PDF]
Andreeva S +17 more
europepmc +1 more source
Reinnervation post-heart transplantation.
A. Grupper, H. Gewirtz, S. Kushwaha
semanticscholar +1 more source
CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang +2 more
wiley +1 more source
Chronic heart failure and heart transplantation: The relationship between autonomic function and cardiac performance. [PDF]
Wu LZ +9 more
europepmc +1 more source
Liver Dysfunction and Early Mortality after Heart Transplant
Jeremy Kobulnik +5 more
openalex +1 more source
D. Chambers +10 more
semanticscholar +1 more source
Collagen type I (Col I) is integrated with self‐assembling peptide RADA16 and loaded with anti‐bacterial peptide SAAP148 to develop a self‐assembled nano‐microstructure hydrogel (Col I‐RADA16‐SAAP148, CRS) without chemical cross‐linkers. CRS exhibits excellent mechanical properties, sustained SAAP148 release to inhibit bacterial infection, macrophage ...
Qian Liu +8 more
wiley +1 more source

